ATL transducer gets PMA

Article

ATL Ultrasound has received supplemental premarket approval (PMA) from the Food and Drug Administration to market a new scanhead, L12-5, for breast imaging applications on the company's HDI 3000 scanner. The transducer features a new design that improves

ATL Ultrasound has received supplemental premarket approval (PMA) from the Food and Drug Administration to market a new scanhead, L12-5, for breast imaging applications on the company's HDI 3000 scanner. The transducer features a new design that improves near-field focus and image quality, according to the Bothell, WA, vendor. ATL has also received PMAs for breast imaging applications with its Ultramark 9 HDI and HDI 3000 systems.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
Emerging Trends with Burnout in Radiology: An Interview with Chris Mattern, MD, Part 1
A Closer Look at the Impact of Expanded Mammography Coverage in Missouri: An Interview with Amy Patel, MD
New Mammography Research Examines Impact of High-Resolution DBT
© 2025 MJH Life Sciences

All rights reserved.